SDF-I BINDENDE NUKLEINSÄUREN

European patent · EP2041282 · In force

Register entry

Publication number
EP2041282
Application number
EP07786160
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jul 18, 2007
Published
Apr 1, 2009
Granted
Jan 3, 2018
Protection ends at the latest
Jul 17, 2027
Next annual fee due
Jul 31, 2026
IPC classes
C12N 15/11 (2006.01)
A61K 38/00 (2006.01)
C12Q 1/68 (2018.01)
Priority
EP 06014957 18.07.2006
PCT application
PCT/EP2007/006387 18.07.2007
PCT publication
WO2008/009437 24.01.2008
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 1, 2025

    Change

    Published in Swissreg on 01.08.2025

  2. Aug 1, 2024

    Change

    Published in Swissreg on 01.08.2024

  3. Aug 1, 2023

    Change

    Published in Swissreg on 01.08.2023

  4. Aug 10, 2022

    Address changed

    Owner
    Noxxon Pharma AG, Max-Dohrn-Strasse 8-10, 10589 Berlin, Germany → TME Pharma AG, Max-Dohrn-Strasse 8-10, 10589 Berlin, Germany

    Published in Swissreg on 10.08.2022

  5. Aug 1, 2022

    Change

    Published in Swissreg on 01.08.2022

  6. Mar 14, 2018

    Agent entered

    Representative
    Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich

    Published in Swissreg on 14.03.2018

  7. Jan 3, 2018

    Granted

    Published in Swissreg on 03.01.2018

Parties

Holder

TME Pharma AG

Max-Dohrn-Strasse 8-10, 10589 Berlin, DE

Agent

Isler & Pedrazzini AG

Postfach 1772, 8027 Zürich

Inventor

PURSCHKE, Werner

13359 Berlin, DE

JAROSCH, Florian

13353 Berlin, DE

EULBERG, Dirk

10437 Berlin, DE

BUCHNER, Klaus

14197 Berlin, DE

MAASCH, Christian

13509 Berlin, DE

DINSE, Nicole

13409 Berlin, DE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.